Kim Björnstrup
Vorsitzender bei Assistance Hr Partners A/S
Profil
Kim Björnstrup is currently the Chairman of Assistance Hr Partners A, Director of Aase Hagemann Holding ApS, Director of Assistance Gastronomie A, and Director of Hagemann Ejendomme A.
In the past, he served as the Chief Executive Officer of Bio Products Laboratory Holdings Ltd.
from 2013 to 2014, Deputy Chairman of Octapharma AG from 1992 to 2010, Chairman of Veloxis Pharmaceuticals A, Chairman of Evaxion Biotech A, and Director of Xeltis AG.
He graduated from the University of Copenhagen.
Aktive Positionen von Kim Björnstrup
Unternehmen | Position | Beginn |
---|---|---|
Assistance Hr Partners A/S
Assistance Hr Partners A/S Personnel ServicesCommercial Services Assistance HR Partners A/S provides staffing services. The private company is based in Frederiksberg, Denmark. | Vorsitzender | - |
Aase Hagemann Holding ApS | Direktor/Vorstandsmitglied | - |
Assistance Gastronomie A/S | Direktor/Vorstandsmitglied | - |
Hagemann Ejendomme A/S | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kim Björnstrup
Unternehmen | Position | Ende |
---|---|---|
Bio Products Laboratory Holdings Ltd.
Bio Products Laboratory Holdings Ltd. Medical DistributorsDistribution Services Bio Products Laboratory Holdings Ltd. operates as a holding company with interests in distributing blood plasma products. It operates business through two subsidiaries which include Bio Products Laboratory Ltd. and DCI Biologicals, Inc. The company was founded on 16 October 2002 is headquartered in London, the United Kingdom. | Vorstandsvorsitzender | 01.05.2014 |
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Direktor/Vorstandsmitglied | 01.10.2010 |
EVAXION BIOTECH A/S | Vorsitzender | - |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Direktor/Vorstandsmitglied | - |
VELOXIS PHARMACEUTICALS A/S | Vorsitzender | - |
Ausbildung von Kim Björnstrup
University of Copenhagen | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
EVAXION BIOTECH A/S | Health Technology |
Private Unternehmen | 8 |
---|---|
Octapharma AG
Octapharma AG Pharmaceuticals: MajorHealth Technology Octapharma AG develops, produces and sells plasma related products for treatment in coagulation disorders and immune diseases. The firm's products include virus-inactivated plasma for transfusion and fractionation products such as coagulation Factors VIII & IX for the treatment of haemophilia, von Willebrand Factor concentrate, prothrombin complex concentrate and immunoglobulins. Octapharma was founded in 1983 and is headquartered in Lachen, Switzerland. | Health Technology |
Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |
Assistance Hr Partners A/S
Assistance Hr Partners A/S Personnel ServicesCommercial Services Assistance HR Partners A/S provides staffing services. The private company is based in Frederiksberg, Denmark. | Commercial Services |
Aase Hagemann Holding ApS | |
Assistance Gastronomie A/S | |
Hagemann Ejendomme A/S | |
Bio Products Laboratory Holdings Ltd.
Bio Products Laboratory Holdings Ltd. Medical DistributorsDistribution Services Bio Products Laboratory Holdings Ltd. operates as a holding company with interests in distributing blood plasma products. It operates business through two subsidiaries which include Bio Products Laboratory Ltd. and DCI Biologicals, Inc. The company was founded on 16 October 2002 is headquartered in London, the United Kingdom. | Distribution Services |